ERIS Share Price Target 2050

CAGR-based price projection for Eris Lifesciences Limited (ERIS) targeting 2050, derived from official NSE exchange closing prices.

Bear Case (-5.0% CAGR)
Rs 347
2050 Target
Base Case (-13.2% CAGR)
Rs 39
2050 Target
Bull Case (-19.9% CAGR)
Rs 6
2050 Target

Current Market Snapshot

CMP: Rs 1,189.80
52W High: Rs 1,488.40
52W Low: Rs 1,189.80
1Y CAGR: -24.7%
3Y CAGR: -13.2%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 1,130 Rs 1,032 Rs 953
2028 Rs 1,074 Rs 896 Rs 764
2029 Rs 1,020 Rs 777 Rs 612
2030 Rs 969 Rs 674 Rs 491
2031 Rs 921 Rs 585 Rs 393
2032 Rs 875 Rs 507 Rs 315
2033 Rs 831 Rs 440 Rs 253
2034 Rs 789 Rs 382 Rs 202
2035 Rs 750 Rs 331 Rs 162
2036 Rs 712 Rs 287 Rs 130
2037 Rs 677 Rs 249 Rs 104
2038 Rs 643 Rs 216 Rs 83
2039 Rs 611 Rs 188 Rs 67
2040 Rs 580 Rs 163 Rs 54
2041 Rs 551 Rs 141 Rs 43
2042 Rs 524 Rs 123 Rs 34
2043 Rs 497 Rs 106 Rs 28
2044 Rs 473 Rs 92 Rs 22
2045 Rs 449 Rs 80 Rs 18
2046 Rs 427 Rs 69 Rs 14
2047 Rs 405 Rs 60 Rs 11
2048 Rs 385 Rs 52 Rs 9
2049 Rs 366 Rs 45 Rs 7
2050 Rs 347 Rs 39 Rs 6

Other ERIS Price Targets

2025 2026 2027 2028 2030 2035 2040

Frequently Asked Questions

What is the ERIS share price target for 2050?

Based on historical growth analysis, the ERIS share price target for 2050 ranges from Rs 347 (conservative) to Rs 39 (base case) to Rs 6 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of ERIS?

The current market price of ERIS (Eris Lifesciences Limited) is Rs 1,189.80. The 52-week high is Rs 1,488.40 and 52-week low is Rs 1,189.80.

Is ERIS a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for ERIS price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at -5.0% CAGR), Base (-13.2% CAGR), and Bull (optimistic at -19.9% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.